Arfaoui Ameni, Sallem Rym Ben, Fernández-Fernández Rosa, Eguizábal Paula, Dziri Raoudha, Abdullahi Idris Nasir, Sayem Noureddine, Ben Khelifa Melki Salma, Ouzari Hadda-Imen, Torres Carmen, Klibi Naouel
Laboratory of Microorganisms and Active Biomolecules, Faculty of Sciences of Tunis, University of Tunis El Manar, Tunis 1068, Tunisia.
Biochemistry and Molecular Biology, University of La Rioja, 26006 Logroño, Spain.
Antibiotics (Basel). 2022 Dec 4;11(12):1755. doi: 10.3390/antibiotics11121755.
This study sought to analyze the antimicrobial resistant phenotypes and genotypes as well as the virulence content of isolates recovered from patients with diabetic foot infections (DFIs) in a Tunisian hospital. Eighty-three clinical samples of 64 patients were analyzed, and bacterial isolates were identified by MALDI-TOF. The antimicrobial resistance phenotypes were determined by the Kirby-Bauer disk diffusion susceptibility test. Resistance and virulence genes, profile, and SCC types were determined by PCR and sequencing. was detected in 14 of the 64 patients (21.9%), and 15 isolates were recovered. Six out of the fifteen isolates were methicillin-resistant (MRSA, -positive) (40%). The isolates harbored the following resistance genes (number of isolates): (12), (B) (2), (A) (1), (2), (M) (2), (K) (3), (L) (1), (6')(2″) (2), (4″) (1) and A (1). The and genes were detected in three isolates. Twelve different -types were identified and assigned to seven clonal complexes with the predominance of -type III. Furthermore, the SCC types III, IV and V were found among the MRSA isolates. Moreover, one MSSA CC398-t571--III isolate was found; it was susceptible to all antimicrobial agents and lacked and genes. This is the first report on the prevalence and molecular characterization of from DFIs and also the first detection of the MSSA-CC398-t571 clone in human infections in Tunisia. Our findings indicated a high prevalence in DFIs with genetic diversity among the MSSA and MRSA isolates.
本研究旨在分析从突尼斯一家医院的糖尿病足感染(DFI)患者中分离出的菌株的抗菌耐药表型和基因型以及毒力成分。对64例患者的83份临床样本进行了分析,通过基质辅助激光解吸电离飞行时间质谱(MALDI-TOF)鉴定细菌分离株。通过 Kirby-Bauer 纸片扩散药敏试验确定抗菌耐药表型。通过聚合酶链反应(PCR)和测序确定耐药基因、图谱和葡萄球菌盒式染色体(SCC)类型。在64例患者中的14例(21.9%)检测到[具体细菌名称未给出],共分离出15株菌株。15株菌株中有6株对甲氧西林耐药(耐甲氧西林金黄色葡萄球菌,MRSA,[具体耐药基因未给出]-阳性)(40%)。这些分离株携带以下耐药基因(分离株数量):[具体基因名称1](12)、[具体基因名称2](B)(2)、[具体基因名称3](A)(1)、[具体基因名称4](2)、[具体基因名称5](M)(2)、[具体基因名称6](K)(3)、[具体基因名称7](L)(1)、[具体基因名称8](6')(2″)(2)、[具体基因名称9](4″)(1)和[具体基因名称10]A(1)。在3株分离株中检测到[具体基因名称11]和[具体基因名称12]基因。鉴定出12种不同的[具体分型名称未给出]类型,并将其归入7个克隆复合体,其中以[具体分型名称13]类型为主。此外,在MRSA分离株中发现了SCC类型III、IV和V。此外,还发现了1株甲氧西林敏感金黄色葡萄球菌(MSSA)CC398-t571--III分离株;它对所有抗菌药物敏感,且缺乏[具体基因名称11]和[具体基因名称12]基因。这是关于DFI中[具体细菌名称未给出]的流行情况和分子特征的首次报告,也是突尼斯人类感染中首次检测到MSSA-CC398-t571克隆。我们的研究结果表明DFI中[具体细菌名称未给出]的流行率较高,MSSA和MRSA分离株之间存在遗传多样性。